Conference Coverage

Tocilizumab Efficacy and Safety for sJIA Sustained at 2 Years

Publish date: November 21, 2011

 

FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF RHEUMATOLOGY

The TENDER trial is sponsored by Roche, the maker of tocilizumab. Dr. Benedetti disclosed relationships with Abbott Laboratories, Bristol-Myer Squibb, Hoffmann-La Roche, Novartis, Novimmune, Pfizer, Roche, and SOBI.

Pages

Recommended Reading

Proposed Criteria Ease JSLE Remission Recognition
MDedge Pediatrics
HPV Vaccine Safe, Effective in Girls with JIA
MDedge Pediatrics
One in Six Newly Diagnosed Pediatric SLE Patients Have Low BMD
MDedge Pediatrics
Registry Updates Blau Diagnostic Criteria
MDedge Pediatrics
FDA Steps Up Cancer Surveillance of TNF Blockers
MDedge Pediatrics
MTX + Prednisone Regimen Improves Outcomes for Early RA
MDedge Pediatrics
Obturator Internus Strain in the Hip of an Adolescent Adult
MDedge Pediatrics
Volar Forearm Compartment Syndrome Following Flexor Digitorum Profundus
MDedge Pediatrics
Subscapularis Tendon Rupture in an 8-Year-Old Boy: A Case Report
MDedge Pediatrics
Idiopathic Chronic Calcific Periarthritis in a Child
MDedge Pediatrics